• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Brand Quest
• The New Manager
• Smartbuy

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth
• Events 2007

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

New Delhi, April 23 Germany-based Fresenius Kabi, the new owners of Dabur Pharma, has announced an open offer to acquire 20 per cent additional stake in the Indian company.

In an announcement made today, Fresenius Kabi said that it intends to acquire up to 3,13,41,260 fully paid-up equity shares of face value Re 1 each. The offer is being made at a price of Rs 76.50 for each share. The offer will open on June 13 and close on July 3.

The open offer follows the acquisition of 73.3 per cent stake in Dabur Pharma by the German company for Rs 878.2 crore. If the open offer is fully subscribed it will cost the company another Rs 240 crore.

More Stories on : Pharmaceuticals | Open Offers | Stocks

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Does futures trading really cause inflation?

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line